Potentially Inappropriate Prescribing for Prostatic Hyperplasia in Older Persons

October 12, 2021

In the context of improved medication management of older patients, we wished to evaluate the overprescription of potentially inappropriate drugs (α1-blockers and 5α-reductase inhibitors [5-ARI]) for benign prostate hyperplasia (BPH). These drugs are considered by geriatricians to increase the risk of falls and pharmacodynamic interactions, but these properties have not yet been proven.